Stocktoria

Bio Green Med Solution, Inc. BGMS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1996-01-01

Bio Green Med Solution, Inc. (BGMS) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $747,000 at a -401.3% net margin.

Chart by TradingView
19/100
Stocktoria Quality Score · grade D
3/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
1 2 2 2 3 1 1 3 2 3 2016201720182019202020212022202320242025
Altman Z″
-18.63 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.92 as of 2026-08-12 · -81.3% 1y
$0.89$4.9452-wk
Market cap USD$3M
Net margin 5y avg-10615.3%
Return on equity 5y avg-985.7%
Beta-0.38

Smart money · insiders, last 12 months

Insiders net sold -$1.4M on the open market · 6 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 9y · down

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 27%
Net marginstronger than 15%
Return on equitystronger than 31%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
BGMSBio Green Med Solution, Inc.3/9
LEXXLexaria Bioscience Corp.4/9
MCRBSeres Therapeutics, Inc.5/912
HYPDHYPERION DEFI, INC.5/9-16.62
ONCOOnconetix, Inc.4/9
BTAIBioXcel Therapeutics, Inc.2/9
RLYBRallybio Corp3/90.76

All Manufacturing companies →

About Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

FAQ

Is BGMS financially healthy?

Bio Green Med Solution, Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).

Does BGMS pay a dividend?

No, Bio Green Med Solution, Inc. does not currently pay a dividend.

How profitable is BGMS?

In FY2025, Bio Green Med Solution, Inc. had a net margin of -401.3% and a return on equity of -43.8%.

Is BGMS a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Bio Green Med Solution, Inc.: a Piotroski F-score of 3/9. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.